Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW – Supply Shortages Could Delay Issuance of Cannabis Retail Licenses in Alberta

The seemingly endless supply shortages ever since recreational cannabis was legalized have started having a domino effect on the Canadian pot industry. The latest news is that the province of Alberta will not issue any more cannabis retail licenses for up to 18 months, unless the supply shortages are addressed by the licensed producers who are mandated to grow and avail cannabis to the recreational and medical cannabis markets.

The Alberta Gaming, Liquor and Cannabis (AGLC) commission made the announcement, adding that the matter was out of their hands.

So far, 65 retail stores were approved and started operating. The province had promised to increase the number to about 250 stores within a year after legalization. However, the ongoing shortages have thrown a spanner in the works, and it may not be possible to hit that target.

Matters may worsen on the supply side if Ontario starts retail sales at the beginning of April next year as planned.

The moratorium on new licenses is biting the business community hard. This is because many of the potential retailers had already leased expensive premises for the retail stores, and now they are continuing to pay rent yet they aren’t operational. For how long can they keep making these rent payments before closing for good?

It isn’t clear what recourse the staff who had already been hired will have in light of this extended delay for new stores to open.

It seems the only winner in this situation is the black market, because consumers keep resorting to the illicit market in order to get what they want. Black market dealers are having a field day meeting the needs of a market that was blown wide open after legalization on October 17.

Meanwhile, Alberta is getting jittery because the delays in licensing new operators may drive investors to Ontario. That capital outflow would take needed tax dollars with it. Alberta is the only province that has so far put a halt on the issuance of new retail licenses.

Their position is understandable given that it makes less sense to bring more retailers on board when the current ones cannot even get half the cannabis that the need to satisfy clients. In fact, it has been widely reported in the local press that buyers are so desperate for recreational cannabis that they are maintaining 24/7 vigilance in order to be first in line when a new consignment of cannabis is delivered to a retail store. The supply chain should have been planned better to avoid such an extended shortage. Sunniva Inc. (CSE: SNN) (OTCQB: SNNVF) and Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) aren’t happy about the bad rap that the industry is getting due to these persistent shortages.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Smoking Cannabis Makes You Less High than Vaping It, Study Finds

As the law and people’s attitude towards marijuana gradually eases up, questions are emerging about how the different methods of consuming marijuana compare against each other. Well, scientists at Johns Hopkins University School of Medicine sought to answer that question by looking into how vaping cannabis differs from smoking it.

With just 17 participants, this study can be aptly described as a small one. However, its findings cannot be discounted when one considers the thoroughness invested in investigating what the researchers had set their minds upon.

First, the study participants were recruited on the basis of being healthy and having abstained from marijuana for at least a month prior to the study. There were eight women and nine men selected for the study.

These selected participants were then given marijuana at varying levels, that is, at concentrations of 0 milligrams (placebo), 10 milligrams and 25 milligrams. This marijuana was given a week apart, and the participants had to consume it within an eight-hour window.

The researchers then subjected the participants to psychomotor and cognitive function tests, tested how much THC was present in their blood, and then recorded their vital signs (pulse, blood pressure, etc.).

Additionally, the study volunteers were asked to complete a questionnaire in which they reported their subjective assessment of how they felt after consuming the cannabis. For example, they were asked to state whether they felted nauseated, anxious, restless or motivated.

The researchers discovered that vaping appeared to trigger stronger effects among the study participants when compared to smoking marijuana, and this was given further credence when lab tests showed that the level of THC in the blood of the participants was higher in the samples taken after they had vaped the substance.

Other scientists who reviewed the findings commended the researchers for focusing on infrequent users of cannabis since all other research centered on regular consumers. Additionally, the methodical approach taken also attracted acclaim.

However, some observers wondered whether the use of pipes to smoke marijuana could give results that were representative of the marijuana joints (cannabis rolled in a paper) that are commonly smoked.

Furthermore, the study participants were asked to vaporize their marijuana three times in quick succession in order to complete their “dose” for the day. This may differ from what people normally do, that is, vaporize once before taking a long break. Consequently, the study could have brought out the extreme effects that are rarely seen among normal users.

Nevertheless, the study provides valuable information that will be useful to particularly individuals taking medical marijuana. This is because such individuals can adjust the dosage based on the method of use. Cannabis companies like Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) and Sugarmade, Inc. (OTC: SGMD) certainly appreciate the insights provided to users and the industry by the research at Johns Hopkins.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Marijuana Could Improve the Memory of Older People, Study Finds

Researchers from the University of Bonn in Germany and Hebrew University in Jerusalem (Israel) have done a study to investigate whether cannabis can improve brain function once endocannabinoid system (ECS) activity is increased by administering cannabis.

Lead researcher Andreas Zimmer and his team got three categories of mice for this study. The first group of mice was two months old while the second group was 12 months old. The third group of mice was 18 months old. These three groups represented the young, mature and old age-groups respectively.

The mice in each age group either received a placebo or had an implant that released THC slowly into the bloodstream. This was done consistently for 28 days after which several days were allowed to elapse with no THC being administered. This abstinence period was referred to as the washout period.

Additionally, all the mice (whether they got THC or a placebo) took part in memory and behavioral tests. For example, one activity involved testing whether the mice recognized other mice to which they had been exposed prior to receiving the placebo or THC.

Another test required the mice to locate a safe platform in a pool of water. The time taken during this activity was recorded for all the mice in the study.

The results of the study were eye-opening. For example, the young mice (the group which was two months old) showed a deterioration in their memory function after receiving THC. In contrast, the mature (12 months old) mice showed an improvement in their memory function. How could this be?

The researchers studied the brain structures of these mature mice and discovered that the brains suddenly looked young (comparable to those of the two-month old mice). Specifically, the hippocampus acquired new synaptic spines, a sign that brain neurons could now communicate more effectively with each other, and thereby heighten brain activity.

In other words, the THC had rewritten the genetic programming of the brains of the mature mice. The researchers used the elimination method to discount any other factor which could be responsible for the improved brain function and the result was that the THC reversed the aging of the brain cells.

What do these results mean for humans? The work done by Zimmer and his team shows a high likelihood that older humans can see improvements in brain function if they consume cannabis. However, this isn’t a certainty until human trials are done and documented. The good news is that Zimmer has already secured funding to study how THC affects memory function in humans.

The study involving human subjects will paint a clearer picture of how cannabis can be used to combat mental decline with age, especially dementia. Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4), SinglePoint, Inc. (OTCQB: SING) and the entire cannabis industry wish Zimmer and his team of researchers all the best in their bid to broaden how much we know about cannabis and its medicinal value.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Australians to Conduct First Marijuana Clinical Trial for Brain Cancer

Two Australians, a naturopath and a neurosurgeon, have teamed up to conduct the first clinical trial in the world aimed at finding out whether cannabis can be used to treat glioblastoma, one of the most aggressive forms of brain cancer.

This type of cancer affects at least 1,000 individuals in Australia alone each year. Sadly, the majority of the patients diagnosed with glioblastoma die within one year and only 5 percent survive for five years after diagnosis.

Dr. Janet Schloss, a naturopath based in Brisbane, and Prof. Charlie Teo, a famous neurosurgeon, have teamed up to explore how patients can have better chances of surviving this cancer if medical cannabis is used alongside the conventional cancer treatments (chemo, radiotherapy and surgery).

The Australian researchers aren’t starting from zero. They have accessed studies conducted in Spain to the effect that medical cannabis inhibits the regrowth of brain tumors in animals. Some human studies have also shown that cannabis may help brain cancer patients to survive for longer.

This research only became possible after Australia made legal changes that permitted the use of some forms of cannabis for medical purposes in 2017. This legal step meant that researchers could now shift from just looking into the side-effects of cannabis consumption to studying how cannabis could be used as a medicine.

Dr. Schloss revealed that she was inspired to do this research after Spanish researchers used cannabis injections to reduce the size of brain tumors. Their research will focus on preventing the regrowth of the brain tumors because patients normally succumb to the condition when suppressed tumors regrow rapidly and cause the death of the patient.

For now, the researchers are recruiting study participants. This stage will be followed by a clinical trial lasting three months in which patients will consume 2ml of cannabis oil each night. The oil was carefully formulated by BioCeuticals to contain as little THC as possible in order to prevent the patients from waking up groggy, or affecting their sleep.

The researchers will document the extent to which cannabis supports the conventional treatments used to treat glioblastoma. The research is being conducted at the Endeavour College of Natural Health, and the New South Wales Ministry of Health has approved the clinical trial. The researchers hope that their findings will increase the options available to the patients who desperately need help in fighting this serious type of cancer. The cannabis community, including companies like Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) and Plus Products Inc. (CSE: PLUS), are waiting with bated breath for the outcome of this groundbreaking research.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Hemp Industry Sees Profitable Harvest as Farm Bill Approaches Finale

CannabisNewsWire Editorial Coverage: With the end in sight for the 2018 U.S. Farm Bill, which contains provisions likely to grant hemp full agricultural legalization, and revenues from existing hemp products rising, hemp farmers are seeing reasons for excitement this fall.

  • The Farm Bill is set to finally pass through Congress in the near future.
  • Predicted hemp revenues for the next few years are soaring.
  • Hemp is doing particularly well in states with supportive politicians, such as Kentucky.

Sugarmade, Inc. (OTC: SGMD) (SGMD Profile) has made the most of this opportunity through investment in Hempistry, a hemp cultivator with big plans for expansion. The popularity of cannabidiol (CBD) products means that hemp may soon surpass the value of other cannabis products, which is providing strong profits for companies such as Tilray, Inc. (NASDAQ: TLRY). This popularity will likely to lead to growth in the food and beverage industry, one reason why Canopy Growth Corp. (NYSE: CGC) (TSX: WEED) has received substantial investment from that sector. HEXO Corp. (OTC: HYYDF) (TSX: HEXO) plans to increase its 310,000 square feet of cannabis cultivation space to almost 1 million square feet by the end of the year. Meanwhile, Aphria (NYSE: APHA) (TSX: APHA) is developing new products to tap into Canada’s lucrative market.

To view an infographic of this editorial, click here.

Hemp Rides High on Wave of Change

Four years ago, it would have been virtually impossible to talk about a hemp industry in the United States. As a variety of the cannabis plant, hemp had been made illegal under legislation decades ago despite not containing significant quantities of the active drug compound that gets marijuana users high from other distinct forms of cannabis. State level reforms had done nothing to protect hemp on a federal level, and the plant was struggling to make its mark.

All that changed with the 2014 Farm Bill, which allowed for the cultivation of hemp at trial and research sites. Together with the emergence of laws in more cannabis-friendly states, this has allowed the industry to take off in a big way. Hemp is being put forward as a potential cash crop to be used in producing fibers, medicines and health foods. Farmers are starting to see big profits from hemp crops. And with fresh legislation on the verge of passing in Washington, the industry appears set for a surge in growth.

Fighting over the Farm Bill

For companies invested in hemp, such as Sugarmade, Inc. (OTC: SGMD), one piece of legislation has dominated the political landscape over the past year — the 2018 Farm Bill.

Farm bills are pieces of legislation passed by Congress every few years as the previous iterations expire. They set out government policies on issues of agriculture and food supply. As complicated pieces of law covering multiple topics, these bills are much haggled over by both houses, and the 2018 bill has been no exception. Divisions over food stamp rules and immigration policy has held up its passage for months.

This year’s farm bill has Sugarmade’s attention because of a section that will remove quality hemp production from drug enforcement restrictions nationwide. Backed by Senate Majority Leader Mitch McConnell, this has been one of the less controversial parts of the bill despite hemp’s illicit history. The possibility of offering struggling farmers a valuable cash crop is one that both parties can get behind.

Unfortunately, this important change for hemp was left in limbo thanks to the other battles over the bill. But now discussions in committee are finally moving towards a finished bill that unifies the House and Senate versions, as the lame duck Republican house majority tries to pass a law it can stomach before control of a dominant voting bloc passes to the Democrats.

Bottom line: the legalization of hemp cultivation could be just days away.

Hemp Heads into the Mainstream

This political change has been facilitated by shifting public attitudes towards hemp. The plant is increasingly popular in food and body care products and has been singled out as one of the top trends for next year by Whole Food Market. That’s good news for Sugarmade, which recently launched its own industrial hemp initiative, as it means there’s not just a consumer market for hemp-derived products but also the political will to make production easier.

These shifts in attitudes are reflected in the varying fortunes of states as well, with some receiving far stronger support for their hemp industry than others. For example, Kentucky’s hemp industry is bolstered by advocacy from the state’s politicians. Congressman James Comer has been outspoken in supporting the state’s industry and in pushing to get the Farm Bill approved.

Sugarmade is among the companies benefiting from Kentucky’s positive attitude towards hemp. The business has invested $1 million in Kentucky hemp company Hempistry to support its high-grade hemp operation for the U.S. market. Harvest of this year’s crop has recently started, following a test harvest of samples by the Kentucky Department of Agriculture (KDA), and the company is inviting interested parties to place bids on the crop. With demand for hemp rising, Hempistry’s legally grown, CBD-rich crop is likely to be in high demand.

Rising Hemp Revenues

One of the reasons behind Sugarmade’s investment in Hempistry is the dramatic rise in revenues from hemp crops. A few years ago, no one could have predicted the popularity hemp would achieve by 2018. The crop was mostly a side note, a reminder of the days when its fibers were used to make ropes and sales. When interest in CBD started to expand, producers realized that it could be extracted from industrial hemp. By turning this interest into a separate industry, businesses could sell CBD without becoming entangled in a mass of legal and social uncertainties.

Companies that have made strong investments in hemp cultivation, such as Sugarmade, will gain considerably from hemp’s ascendancy, to the benefit of managers and common share investors. Jimmy Chan, CEO of Sugarmade, commented, “Demand for industrial hemp and products derived from hemp is soaring with no let up in sight. We expect our direct investment into Hempistry to be accretive to common shareholders, and our supply agreement to be lucrative. All of us at Sugarmade see a tremendous opportunity to become a supplier to this fast-growing sector.”

Expanding the Hemp Harvest

With the hemp market growing so fast and the Farm Bill promising to make hemp farming easier, many companies are looking to expand their operations. Having just harvested 100 acres of CBD-rich hemp, Hempistry is focusing on achieving a 10-fold increase in its acreage next year, which would make it one of the largest hemp cultivators in North America.

This expansion is happening alongside that of companies in the related cannabis sector. In Canada, recreational legalization has been big news for companies such as Tilray, Inc. (NASDAQ: TLRY), one of the largest cultivation companies in the country. A leader in research, production and distribution, Tilray has seen staggering financial growth over the past year, with an 85 percent rise in revenue during the third quarter and a 78.9 percent rise for the year to date. Legal and social changes have created the space for a substantial new industry to flourish across North America and beyond, bringing in big bucks for the companies that pioneered the sector.

Growth into the beverage and whole food markets is a likely next step for many hemp and cannabis companies, and big players on the inside of those industries have started to take note. Constellation Brands, a leading American beverage manufacturer, has invested billions of dollars in Canopy Growth Corp. (NYSE: CGC) (TSX: WEED), one of the largest cannabis growers in Canada. Canopy Growth is relatively small fry compared to the power of Constellation Brands, but the funds such a corporate giant can spare make a big difference in an emerging industry. The result is likely to be the development and marketing of CBD-infused foods and drinks, pushing the industry into places it hasn’t previously reached.

HEXO Corp. (OTC: HYYDF) (TSX: HEXO) produces cannabis through its Hydropothecary brand and recently announced plans to develop nonalcoholic, cannabis-infused beverages with Molson Coors Canada. This joint venture with one of the world’s biggest beer makers is a significant move to position HEXO in the burgeoning cannabis-infused drinks market. The company also announced that it has closed on the acquisition of its first major facility outside of Quebec.

Aphria (NYSE: APHA) (TSX: APHA) has also seen rising revenues and profits since 2016, thanks to the growth of this innovation-led market. It recently announced a collaboration with Perennial, Inc., to develop products for the Canadian market, a critical region for any company looking to expand beyond the United States.

With hemp revenues on the rise and politicians about to ease the way for hemp farmers, this is a sector that’s likely to keep growing in strength for years to come.

For more information on Sugarmade, visit Sugarmade, Inc. (OTCQB: SGMD)

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – Why Cannabis Capsules are Gaining Popularity

This year saw three Canadian cannabis companies introduce marijuana capsules on the market following the lead taken by Tilray last year. This year also saw UC San Diego get permission from the DEA to import marijuana capsules for a clinical trial. So, what’s the deal with capsules? Why are they suddenly becoming popular?

The first reason why capsules are a hit in the market is because physicians and consumers find them convenient when one doesn’t want to make mistakes when measuring the quantity to consume, especially patients taking marijuana as a way to alleviating their medical conditions. The medical cannabis dispensary can simply advise the patient to take two capsules a day, or whatever number may be deemed necessary for a specific patient. Those instructions will be easier to follow, consistently, since the process of deciding how much cannabis to take is easy.

Secondly, it is easy to transport the cannabis capsules in case one needs a supply close by. For example, you can simply count out the number of capsules you will need for the days when you are going to be away from home. This is different from having to carry an entire bottle of cannabis oil, for example, thereby exposing it to the risk of total loss in case it spills or degrades due to the unfavorable conditions in which you are carrying the product.

Additionally, cannabis capsules are useful for those people who find themselves in environments where it isn’t possible for them to consume cannabis in the most common ways, such as by smoking or vaping it. Such a person can just pop a capsule (or two or three) and get on with whatever he or she was doing, and none nearby will be the wiser.

Let’s face it, marijuana is still a divisive substance, regardless of what the law says in various jurisdictions. Consequently, consumers often face varying levels of stigmatization as they exercise the freedom granted by law to consume cannabis either for medical or recreational reasons. Once again, capsules can come to the rescue of the individuals who want to be discreet regarding their use of marijuana.

However, it isn’t all rosy for cannabis capsules just yet.

One shortcoming of cannabis capsules is that they cannot be standardized as yet since every individual requires a different quantity of marijuana in order to get the desired effects, whether it is feeling high or getting relief from the symptoms of a medical condition. It may therefore be expensive to ask for the contents of capsules to be customized for your needs, or you will have to make do with the estimated contents from mass-produced capsules.

The other question is: do you prepare the capsules yourself, or buy them from a manufacturer/retailer like MedReleaf Corp.? The source of the capsules is important because it will determine whether you are getting a consistent quality and quantity of cannabis that can trigger the desired effects. For now, buying from a licensed producer or dispensary seems a better route than going the DIY way.

As you can see from the discussion above, marijuana capsules look set to rise to higher levels over the years because of the many advantages that they bring. Industry insiders like Medical Cannabis Payment Solutions (OTC: REFG) and Net Element (NASDAQ: NETE) welcome every innovation, such as capsules, which makes it easier for people to access the cannabis they need for different purposes.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Consuming Legal Marijuana in Massachusetts Could Still Get You Fired

In one of the ironies surrounding recreational marijuana, anyone who tests positive for the substance can legally be fired even if state law permits the consumption of cannabis by adults. Several employers polled in Massachusetts admitted that they would continue random drugs tests. They cite a number of reasons for this.

First, many employers revealed that testing employees and firing those who test positive for the metabolites of THC helps those employers to pay lower insurance premiums. This is especially true for companies that involve the use of heavy machinery. Lower premiums mean more savings for company owners.

Secondly, employers are concerned about the safety of their customers. For example, would you be comfortable allowing someone who is under the influence of cannabis to service your pool at home?

Another reason given by employers who insist that they will continue testing their employees for drugs (and making hiring decisions based on the test results) is that those employers have a duty to ensure that their employees are safe at the workplace. Maintaining a drug-free work environment is one of the ways to protect employees from many avoidable hazards.

However, recruiters say those who conduct pre-employment drug testing are increasingly becoming the minority among employers in the state. This is because such a procedure tends to eliminate a significant fraction of job applicants because marijuana is widely consumed ever since it became legal.

Mayo Clinic reveals that anyone who consumes marijuana just once can have the metabolites of the substance in their urine for up to three days. The duration within which these metabolites can be detected increases based on how often one consumes cannabis. For instance, daily users peak at more than 30 days within which cannabis can be detected after the last time they consumed the substance.

The law legalizing marijuana in Massachusetts calls on employers to implement reasonable protections for employees who have a medical marijuana card issued by the state. Those are the only employees who may escape punitive action if they tested positive for THC metabolites during pre-employment screening or random testing once they are on the job.

But, why is there such a contradiction in the law? Federal law takes precedence over state law on many employment issues, such as the laws regarding an employer’s liability for the welfare of his or her employees. Consequently, state law permits people to consume recreational marijuana but leaves the door open for employers to take action against workers who test positive and create risks for the company.

These contradictions will only end once the federal government finally decides to legalize marijuana. How far off will that be? Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), Marijuana Company of America Inc. (OTC: MCOA) and other industry players can’t wait to see the end of prohibition at the federal level.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Cannabis Cultivation Powering Growth for the Industry

CannabisNewsWire Editorial Coverage: Cultivation by both large and small growers is powering growth across the cannabis industry.

  • Cultivation is fueling the growth of the cannabis industry.
  • $718 million was invested in cultivation and retail last year as the industry continued to grow.
  • Raw materials from cultivators are used in a wide range of cannabis products.
  • Cultivation locations are critical to distribution channels and partnerships.

Within this growing industry, Cannabis Strategic Ventures (OTC: NUGS) (NUGS Profile) is working to foster emerging brands by targeting investment through a la carte partnerships and acquisitions. Tilray, Inc. (NASDAQ: TLRY), one of Canada’s largest cultivators, has seen earnings rise 78.9 percent so far this year thanks to growing demand and a maturing business. Cultivation means profits for hydroponics suppliers such as GrowGeneration Corp. (OTCQX: GRWG), which provides the materials growers need. Some companies are working to stand out through branding, such as the feel-good ethos of Charlotte’s Web Holdings, Inc. (OTCQX: CWBHF) (CSE: CWEB). Others, such as Aurora Cannabis, Inc. (NYSE: ACB) (TSX: ACB), are working with local authorities to reach new customers.

To view an infographic of this editorial, click here.

Cannabis Cultivation

When economic historians look back on the early 21st century, the cannabis industry will likely feature prominently in conversations. The industry, which has operated in the black market since the turn of the millennium, has grown to a revenue cap of over $9 billion in the United States alone, with an expected value of $47.3 billion by 2027. From retail outlets to research groups, edibles, technology, vaping liquids to health supplements, cannabis has become a diverse and powerful industry.

Underlying it all is cultivation. As much the work of craft businesses as of big corporations, cultivation supplies the plants without which none of the rest would be possible. Licensed growers are providing the materials needed to drag cannabis profits away from funding crime and turning them into a legal, taxable, sustainable industry.

Cultivators make the cannabis industry possible.

The Growth of Cultivation

Cannabis cultivation is hardly a new activity in the United States, but a legal, corporate-fronted version of it is. Since the first medical legalization in California in 1996, many respectable growers have sprung up, whether as new businesses entering the emerging market or as once-clandestine farmers turning their previously illegal operations into law-abiding producers. In today’s cannabis environment, many corporate-fronted companies, such as Cannabis Strategic Ventures (OTC: NUGS), are eyeing small to large commercial cultivation as part of their business model.

This interest of Cannabis Strategic Ventures shows how quickly cannabis cultivation has acquired the trappings of a legally established industry. As a publicly traded company that incubates, develops and partners with brands, Cannabis Strategic Ventures is a sort of meta-business that emerges in sophisticated markets — bolstering the development of production, services and retail through its application of business acumen and strategically applied capital.

It’s not surprising that such companies are engaging with cannabis cultivation. Investment in cannabis cultivation and retail reached $718 million last year as investors were increasingly drawn to this growing and profitable market. Looking ahead, the trend shows no sign of declining.

Cannabis cultivation is a specialist form of agriculture, requiring an understanding of hydroponics, plant strains and environmental factors that affect the potency of crops. Acquiring those skills hasn’t been easy, especially given how long the industry operated in the shadows, its techniques and collective knowledge shared only through illicit channels. As cultivation takes off, the industry needs the support of companies such as Cannabis Strategic Ventures to acquire equipment, train staff and build facilities to meet the demand of a growing customer base.

Cultivation is fundamental to the market, so the sector is a natural target for investors looking to ensure a lasting place in the cannabis industry. Cannabis Strategic Ventures is actively seeking out cultivation facilities with existing infrastructure to speed up its move into cultivation. This initial step provides a foundation upon which much bigger moves can be built.

Building on the Foundations of Cultivation

Growers aren’t just selling the plants as the dried or refined forms of cannabis that users have been consuming for decades. With legality, cultivators have experimented with different ways cannabis can be used. Much of the plant is still sold for smoking, but some of the valuable crop is turned into products such as vaping liquid, oils, capsules, drinks and other consumables. Cannabidiol (CBD) and hemp phytocannabinoids, nonpsychoactive chemicals that appears in cannabis alongside the high-inducing THC, have become the core ingredient of a range of products as research and design departments find ways to use it for health, well-being and relaxation.

The range of brands in the Cannabis Strategic Ventures portfolio reflects this varied approach to cannabis and its derivatives through commitments in category leaders in the space. None of these brands would be possible without the cultivation of cannabis plants. Bringing cultivation under the same umbrella as the products will offer opportunities for improved efficiency and profitability. By sourcing cannabis from its own facilities, Cannabis Strategic Ventures should be able to achieve vertical integration in the supply chain, which naturally leads to greater certainty over the supply of raw materials and increased efficiencies into the system, likely cutting costs and improving the timeline from cultivation to shelf.

The growth of cannabis cultivation has led to a boom for support services as well, such as the provision of staff and hydroponic equipment. Here, too, efficiencies can be realized through vertical integration as cultivators work more closely with their suppliers.

This is yet another way Cannabis Strategic Ventures may benefit if cultivation is brought in-house. As the owner of BudHire, a subsidiary specializing in cannabis industry recruitment, the company looks to be in an ideal position to source the most skilled staff for its facilities.

Cultivation in California

Geography makes a big difference to U.S. cannabis companies. The industry isn’t legal in every state, and among those that have legalized, the laws vary substantially from state to state, as do market sizes. Given the challenges of working across state lines without federal legal reform, being based in the right location can be critical.

Cannabis Strategic Ventures is headquartered in Los Angeles and benefits from easy access to the oldest, largest and most complex legal cannabis market in the United States. Many growers in California are now trying to transition from the black market to the legal one, but the move can be challenging. Volumes of cannabis that could have been sold for $3,000 illegally go for a fifth of that price now. Growers must pay taxes and work within well-defined regulations. Working with firms such as Cannabis Strategic Ventures, which offers essential financial and intellectual capital, can help a grower make the transition more successfully.

Being located in California, therefore, provides two significant advantages for a company such as Cannabis Strategic Ventures. On one hand, the state has a large consumer base for the company’s products and services. On the other hand, it has a plentiful supply of small companies looking for financial support, creating opportunities for growth through mergers, acquisitions and partnerships.

Colleagues and Competitors in Cultivation

Cannabis Strategic Ventures is not alone in its interest in this promising industry. An impressive variety of companies are now cultivating cannabis.

Tilray, Inc. (NASDAQ: TLRY) is one of the largest cultivation companies in Canada, a country with a fast-growing and well-regulated market. A global pioneer in production, distribution and research in the cannabis market, Tilray was the first licensed producer of medical cannabis in the world to have its facility Good Manufacturing Practices (GMP)-certified in accordance with European Medicine Agency (EMA) standards. Its recent earnings report reflected the extraordinary growth being experienced by well-run cannabis companies, with an 85 percent rise in revenue in the third quarter and a 78.9 percent rise for the year to date. With recreational cannabis having just become legal in Canada, this growth is likely to continue that increase over the next few years.

The growth of such companies has provided a boost for GrowGeneration Corp. (OTCQX: GRWG), a supplier of hydroponic systems and the nutrients used with them. Like Cannabis Strategic Ventures, GrowGeneration has been acquiring other companies to expand its presence within the market. It also has an eye on reaching different market sectors. The company recently established the GrowGeneration Hemp Corp subsidiary to market its products to hemp farms and GrowGeneration Canada to sell to Canadian cultivators.

In this booming market, branding is crucial to help companies stand out from the pack. Charlotte’s Web Holdings, Inc. (OTCQX: CWBHF) (CSE: CWEB) is winning over customers with the feel-good factor as a company committed not just to sales but to improving the planet and people’s lives. Given the correlation between cannabis use and liberal values, adopting such a strong identity seems to be bringing the company success.

For Aurora Cannabis, Inc. (NYSE: ACB) (TSX: ACB), the recent focus has been on reaching new customers. As a Canadian company, Aurora is looking to profit from the country’s legalization of recreational cannabis in mid-October this year. The market is regulated on a regional basis, so Aurora has been busy setting up agreements with local authorities to give it a strong reach across the country and even stretching into international markets.

With revenues rising and markets growing, cannabis cultivators are seeing a period of great expansion, making the growth of a whole industry possible.

For more information on Cannabis Strategic Ventures, visit Cannabis Strategic Ventures, Inc. (NUGS)

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – Millennial Consumers Drive the Market for Craft Marijuana

As more states and countries around the world legalize marijuana, a new trend is emerging where some consumers are ditching the “cheap, generic” cannabis for specialty “craft” products. Millennials are the largest fraction of this connoisseur group of consumers.

It is true that marijuana prices have been dropping like a rock ever since cannabis was legalized in different states. Such price drops target making marijuana affordable to the mass market that is simply interested in getting hold of some cannabis for recreational (adult-use) or medical purposes.

Like all products, however, a segment of the consumers is more discerning and is willing to pay more for an artisan product which is superior to the mass market variety.

These high-end consumers pay more attention to the specific characteristics of the different strains and where those strains were grown (and, of course, how they were grown).

The tastes of these high-end consumers would not widely differ from what is seen in the wine industry where certain consumers look down on those who imbibe the cheap stuff. Call it some form of snobbery if you like, but it is a differentiation in the market that can make some entrepreneurs very rich once they address the needs of those niche markets.

It isn’t far-fetched to think of an “appellation system” for the cannabis industry where some strains are legally connected to certain geographical locations. Once again, lessons abound in the wine industry where champagne is from a particular region of France for quality reasons. The same can easily exist for the marijuana industry.

More attention is likely to be paid to the quality of marijuana as the industry matures. Don’t imagine that quality is entirely dependent on how much THC or CBD is in a given product. After all, alcohol quality doesn’t depend on the alcohol content of a given alcohol brand.

Other attributes, such as flavor, mood enhancement and medicinal value, will take on increasing importance for both cultivators and consumers.

All these benefits will start taking shape when cannabis is legalized more widely, such as at the federal level in the US. As things stand, companies are barely able to make a profit from the mass market, so it can be hard for them to invest for niche markets that aren’t sizeable enough as yet.

For now, one can only look forward to a future where there will be cannabis on the shelves for every kind of consumer, including those who demand and can afford artisan marijuana products. Green Hygienics Holdings Inc. (OTC: GRYN), GreenBox POS, LLC (OTC: GRBX) and other cannabis companies feel that future isn’t as far off as one may think.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Does Marijuana Legalization Bring Economic Salvation or Just Hype?

One of the major arguments made in favor of marijuana legalization is that it will bring economic transformation to the community. The states that have so far legalized cannabis seem to give credence to this expectation. However, could marijuana legalization have another side that legislators and advocates don’t pay ample attention to?

It is a given that tax dollars start flowing into state coffers when cannabis is legalized. This is because every sale made attracts state and local taxes that are remitted to the relevant entities. Cannabis criminalization just creates business for the criminal world without bringing any benefits to the state or local community.

Secondly, contractors and real estate agents earn even before legal sales begin. This is because these professionals get to work setting up the places from which the legal sale of cannabis will take place.

Thirdly, law enforcement personnel and other resources are diverted to address other pressing law enforcement priorities instead of being saddled with chasing down petty criminals for possessing marijuana.

Furthermore, tourism also booms when marijuana legalization takes place. Just think about the thousands or millions of people who will visit Planet 13 in Las Vegas each year! Jobs are also created once retail sales begin, and those jobs generate more taxes and other benefits. In fact, research has it that every dollar that goes to legal weed generates at least $2.4 in economic activity.

But, there is another side that needs to be considered as well.

Marijuana companies seem to be engaged in a race to the bottom when one considers the rate at which cannabis prices are dropping. As the recent MJBizCon in Las Vegas showed, innovative ways to grow cannabis are being introduced and those techniques will bring the cost of cannabis even lower.

Lower prices affect the taxes collected by states where cannabis is legal. The drop in tax collections can get so serious that some states (Colorado, for example) are raising the rates in order to shore up tax revenues from the industry.

Another unwanted outcome of the dropping marijuana prices is that cannabis companies are tittering on the brink of bankruptcy due to reduced profitability. This threatens the jobs and taxes anticipated from the industry in the long run.

California is pioneering the way forward by changing from taxing marijuana based on the price at which it has been sold to taxing it based on the weight of the product. It is hoped that this new approach will allow cannabis companies to retain more revenue and stay afloat.

However, a better prospect for the industry would be the legalization of cannabis at the federal level. How would this help the industry? It would remove the current forced fragmentation where each company has to set up infrastructure for the entire value chain in each state where it operates.

Marijuana would cross state lines, so the players are likely to consolidate their operations and lower operational costs in order to lock in more profits. Additionally, access to international markets would also help to bolster revenues and protect the local economy.

All in all, the few shortcomings seen above pale in comparison to the massive benefits observed after legalization. Cannabis companies like Global Payout, Inc. (OTC: GOHE) and Golden Developing Solutions, Inc. (OTC: DVLP) are certainly optimistic about the future of the industry, and that is why they are continuing to invest massively in their operations.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com